Dsm Capital Partners LLC Neurocrine Biosciences Inc Transaction History
Dsm Capital Partners LLC
- $6.44 Billion
- Q3 2024
A detailed history of Dsm Capital Partners LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Dsm Capital Partners LLC holds 944,154 shares of NBIX stock, worth $129 Million. This represents 1.69% of its overall portfolio holdings.
Number of Shares
944,154
Previous 997,784
5.37%
Holding current value
$129 Million
Previous $137 Million
20.87%
% of portfolio
1.69%
Previous 2.0%
Shares
23 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.36 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$703 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$351 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$254 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...